Metabolic Bone Diseases and Total Hip Arthroplasty: Preventing Complications.

Joaquin Moya-Angeler, Joseph M Lane, Jose A Rodriguez

Journal: The Journal of the American Academy of Orthopaedic Surgeons 2018;25(11):725-735

PMID: 29059109

Abstract

Metabolic bone diseases are a diverse group of conditions characterized by abnormalities in calcium metabolism and/or bone cell physiology. These unbalanced processes can eventually lead to bony deformities and altered joint biomechanics, resulting in degenerative joint disease. Not infrequently, patients with metabolic bone diseases have restricting hip joint pain that ultimately necessitates hip arthroplasty. To minimize complications, the surgeon must consider the particular characteristics of these patients. The surgical and medical management of patients with metabolic bone diseases undergoing hip arthroplasty requires appropriate preoperative diagnosis, careful attention to the technical challenges of surgery, and strategies to maximize the long-term results of the surgical intervention, such as the use of bone anabolic and anticatabolic agents.

Address: From the Department of Orthopaedics, Lenox Hill Hospital, New York, NY (Dr. Moya-Angeler and Dr. Rodriguez), and the Hospital for Special Surgery, New York, NY (Dr. Lane).
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.